Given that exosomes from metastatic medulloblastoma cells, carrying higher levels of MMP-2 and EMMPRIN could confer an invasive phenotype on recipient cells, we decided to test the direct contribution of MMP-2 and EMMPRIN by genetic knockdown (Supplementary Figure S7A,B). This evidence concerns the gene MMP2 and medulloblastoma.